In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

For the third year in a row, Carver Bank, the largest Black-owned financial institution, brought prostate cancer screenings.

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, a technology company leading the adoption of AI to advance precision ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive ...

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers Will Be Presented at the 2025 ASCO GU Symposium.

Ibex Prostate Detect is designed to help pathologists catch small and rare cancers in whole-slide images from tissue biopsies that they might've missed.

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

One of the most prevalent cancers in males is prostate cancer, yet little is known about it. Results can be greatly enhanced ...

A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Myriad Genetics (MYGN) and Lumea have signed an agreement to integrate Myriad’s advanced molecular diagnostic tests – Prolaris Prostate Cancer ...